P

Inventor

VARNEY MICHAEL D

US26 patents
⚠️ This page may combine multiple inventors who share the name “VARNEY MICHAEL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AGOURON PHARMA

25 patents
US5707992AJan 13, 1998

Antiproliferative quinazolines

AGOURON PHARMA44 citations95
US5608082AMar 4, 1997

Compounds useful as antiproliferative agents and GARFT inhibitors

AGOURON PHARMA27 citations92
US5885996AMar 23, 1999

Antiproliferative quinazolines

AGOURON PHARMA36 citations90
US5646141AJul 8, 1997

Compounds useful as antiproliferative agents and GARFT inhibitors

AGOURON PHARMA17 citations81
US5739141AApr 14, 1998

Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds

AGOURON PHARMA9 citations73
US5726312AMar 10, 1998

Methods for preparing antiproliferative 5-substituted pyrimidone compounds

AGOURON PHARMA7 citations73
US5641774AJun 24, 1997

Compounds useful as antiproliferative agents and garft inhibitors

AGOURON PHARMA6 citations73
US5639749AJun 17, 1997

Compounds useful as antiproliferative agents and garft inhibitors

AGOURON PHARMA3 citations73
US5625061AApr 29, 1997

Compounds useful in preparing antiproliferative agents and garft inhibitors

AGOURON PHARMA3 citations73
US5594139AJan 14, 1997

Processes for preparing antiproliferative garft-inhibiting compounds

AGOURON PHARMA7 citations73
US6525050B1Feb 25, 2003

(4-oxo-2-pyrimidinyl)thioalkyl compounds useful as AICARFT inhibitors

AGOURON PHARMA11 citations69
US6207670B1Mar 27, 2001

Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds

AGOURON PHARMA1 citations62
US5981748ANov 9, 1999

Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates

AGOURON PHARMA2 citations62
US5945427AAug 31, 1999

Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds

AGOURON PHARMA3 citations62
US5831100ANov 3, 1998

Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates

AGOURON PHARMA1 citations62
US5641771AJun 24, 1997

Compounds useful as antiproliferative agents and garft inhibitors

AGOURON PHARMA1 citations62
US5639747AJun 17, 1997

Compounds useful as antiproliferative agents and garft inhibitors

AGOURON PHARMA1 citations62
US5610319AMar 11, 1997

Compound useful as antiproliferative agents and GARFT inhibitors

AGOURON PHARMA1 citations62
US6001851ADec 14, 1999

HIV protease inhibitors

AGOURON PHARMA4 citations60
US5574039ANov 12, 1996

Antiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituents

AGOURON PHARMA3 citations59
US6953858B2Oct 11, 2005

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

AGOURON PHARMA4 citations57
US5498727AMar 12, 1996

Preparation of benzindole compounds from naphthalene compounds

AGOURON PHARMA3 citations55
US6323210B2Nov 27, 2001

Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds

AGOURON PHARMA0 citations51
US7179918B2Feb 20, 2007

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

AGOURON PHARMA0 citations47
US5545744AAug 13, 1996

Cyano naphthalene compounds

AGOURON PHARMA1 citations45

AGOURON PHARMACETICALS INC

1 patent